Copyright
©The Author(s) 2019.
World J Hepatol. Feb 27, 2019; 11(2): 226-233
Published online Feb 27, 2019. doi: 10.4254/wjh.v11.i2.226
Published online Feb 27, 2019. doi: 10.4254/wjh.v11.i2.226
Parameters | Reference range |
White blood cell count - 15.3 | 4.5-11 K/uL |
Hematocrit - 44.5 | 34%-47% |
Hemoglobin – 13.6 | 11.7-15 g/dL |
Platelet count – 376000 | 150-450 K/uL |
Blood urea nitrogen - 42 | 7-20 mg/dL |
Creatinine – 1.28 | 0.5-1.1 mg/dL |
AST - 17 | < 36 U/L |
ALT - 23 | < 46 U/L |
Total bilirubin - 2.0 | 0.1-1.2 mg/dL |
Direct bilirubin – 1.0 | < 0.9 mg/dL |
gGT - 145 | 0-60 IU/L |
Total protein – 6.4 | 6-8.3 g/dL |
Albumin – 2.6 | 3.5-5.0 g/dL |
Erythrocyte Sedimentation rate - 68 | (0-24 mm/h) |
C-reactive protein – 78.32 | < 5.1 mg/L |
INR – 1.0 | 0.9-1.1 |
C3 - 156 | 90-180 mg/dL |
cANCA - negative | Negative |
pANCA - negative | Negative |
Rheumatoid factor - < 15 | 0-15 IU/mL |
Anti-SSA – negative | Negative |
Anti-SSB – negative | Negative |
Anti-CCP – negative | Negative |
RPR – non-reactive | Non-reactive |
Cryoglobulins – negative | Negative |
Antinuclear antibodies - negative | Negative |
AntidsDNA – negative | Negative |
HIV RNA – undetectable | < 20 copies/mL |
CD4 – 564/25% | Cells/mL |
HCV-RNA – 346755 genotype 1B | < 15 IU/mL |
HCV | HIV | Zinc deficiency | Diagnosis | Treatment | |
Srisuwanwattana et al[1] | Yes | NA | No | Skin biopsy | Zinc supplementation and topical steroids |
Kapoor et al[2] | Yes | NA | Yes | Clinical diagnosis | Oral zinc supplementation |
Jakubovic et al[3] | No | NA | Yes | Skin biopsy | Nutritional Supplementation |
Abdallah et al[5] | Yes | NA | No | Skin biopsy | Zinc supplementation |
Pernet et al[7] | No | NA | No | Skin biopsy | Resolved spontaneously |
Tabibian et al[8] Case 1 | Yes | NA | Yes | Skin biopsy | Zinc supplementation |
Tabibian et al[8] Case 2 | Yes | NA | Yes | Skin biopsy | Zinc supplementation |
Das et al[9] | No | NA | NA | Skin biopsy | Zinc supplementation |
Najarian et al[12] | Yes | Yes | Yes | Skin biopsy | Zinc supplementation |
Shumez et al[15] | Yes | NA | Yes | Skin biopsy | Zinc supplementation |
Shaikh et al[16] | Yes | NA | No | Skin biopsy | Ledipasvir/sofosbuvir |
Wu et al[17] | No | NA | NA | Skin biopsy | Systemic steroids |
Rahman et al[18] | Yes | NA | NA | Skin biopsy | Systemic steroids and zinc supplementation |
Botelho et al[19] | Yes | NA | Yes | Skin biopsy | Zinc supplementation |
Panta et al[20] | No | NA | Low normal levels | Skin biopsy | Oral zinc supplementation and topical steroids |
Pandit et al[21] Case 1 | No | NA | Yes | Skin biopsy | Oral zinc supplementation |
Pandit et al[21] Case 2 | No | NA | Yes | Clinical diagnosis | Oral zinc supplementation |
- Citation: Oikonomou KG, Sarpel D, Abrams-Downey A, Mubasher A, Dieterich DT. Necrolytic acral erythema in a human immunodeficiency virus/hepatitis C virus coinfected patient: A case report. World J Hepatol 2019; 11(2): 226-233
- URL: https://www.wjgnet.com/1948-5182/full/v11/i2/226.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i2.226